Lightbeam Health Triumphs Again as KLAS Champion for RPM
![Lightbeam Health Triumphs Again as KLAS Champion for RPM](/images/blog/ihnews-Lightbeam%20Health%20Triumphs%20Again%20as%20KLAS%20Champion%20for%20RPM.jpg)
Lightbeam Health Solutions Achieves Prestigious Award
Lightbeam Health Solutions, recognized nationwide for its leadership in population health enablement technology, has once again demonstrated its commitment to excellence by winning the Best in KLAS award for Remote Patient Monitoring (RPM). This accolade comes with an impressive satisfaction score of 93.6 out of 100 for its innovative Deviceless RPM solution.
The Significance of the Best in KLAS Award
The Best in KLAS: Software and Services Awards has become a hallmark of success for software companies in the healthcare sector. This award is a culmination of feedback that reflects the experiences of healthcare professionals striving to enhance patient care. By achieving this accolade, Lightbeam is not only recognized as a leader but also as a trusted partner in healthcare technology.
Innovative Approach to Patient Engagement
At the heart of Lightbeam's offering is its Deviceless RPM. This approach enables organizations to drive value-based care through increased staff efficiency and enhanced patient outreach. By utilizing text messages and phone calls, the Deviceless RPM engages patients directly, facilitating data collection across a variety of health conditions such as chronic heart failure (CHF), chronic obstructive pulmonary disease (COPD), diabetes, and maternal health.
Impact of Deviceless RPM on Healthcare Providers
Lightbeam's innovative Deviceless RPM has shown remarkable capacity to generate clinical and financial benefits for healthcare providers. This success is validated through numerous peer-reviewed studies that highlight its effectiveness in improving patient outcomes and showcasing client success stories.
Words from Leadership
“We are honored to be top-ranked for the second consecutive year,” said Pat Cline, CEO of Lightbeam. He emphasized that this recognition is a testament to the company's dedication to empowering healthcare organizations with tools that foster meaningful change. The commitment to improving patient outcomes, maximizing savings, and advancing health equity initiatives remains paramount.
Future Directions for Lightbeam Health Solutions
Lightbeam continues to leverage its position as AMGA’s Exclusive Partner for Analytics and Population Health Management. The organization is well-equipped to support value-based care organizations using Best in KLAS Deviceless RPM. By integrating social determinants of health (SDoH) factors and scaling care management for at-risk patient groups, Lightbeam significantly enhances its impact across the healthcare landscape.
Engagement at Upcoming Events
The 2025 Best in KLAS report is now accessible for those looking to delve deeper into the findings that underscore the milestones achieved by leading health tech firms like Lightbeam. Furthermore, they will be present at the HIMSS 2025 event, offering insights and opportunities for collaboration with healthcare providers from March 3-6.
What This Means for the Healthcare Community
Lightbeam's continuous innovation and research enable it to meet and exceed the demands of a constantly evolving healthcare landscape. By providing decision-makers with data-driven insights, they facilitate improved healthcare delivery and operational efficiency across the sector.
About KLAS Research
KLAS Research is a firm focused on enhancing healthcare by providing reliable insights to software and service providers. By collaborating with thousands of healthcare professionals, KLAS delivers performance data that empowers vendors to improve their services significantly.
About Lightbeam Health Solutions
Lightbeam Health Solutions has earned its reputation through a proven approach to managing patient populations effectively. Their platform combines analytics with a user-friendly interface, ensuring payers and providers have the necessary tools to improve care and achieve success across multiple healthcare arrangements.
Frequently Asked Questions
What is the Best in KLAS award?
The Best in KLAS award recognizes top-performing software and service providers in healthcare based on feedback from professionals in the field.
What does Lightbeam Health Solutions offer?
Lightbeam provides innovative population health management solutions that improve patient outcomes and streamline care management.
How has Lightbeam performed in recent KLAS awards?
Lightbeam achieved a satisfaction score of 93.6 for Remote Patient Monitoring in the 2025 Best in KLAS Awards.
What is Deviceless RPM?
Deviceless RPM is Lightbeam’s patient engagement solution that utilizes text and phone communication to collect health data without requiring any physical devices.
Where can I learn more about Lightbeam?
You can visit Lightbeam's official website for information on their services, solutions, and recent developments.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.